Abbreviations |
|
xix | |
Glossary |
|
xxi | |
|
1 Introduction to the causes of cardiovascular disease and type 2 diabetes mellitus, South Asians, and the structure and approach of this book |
|
|
1 | (37) |
|
|
1 | (1) |
|
|
2 | (1) |
|
1.3 Introduction to the puzzle of South Asians' high susceptibility to CVD and DM2 using an example from Scotland and the aims of this book |
|
|
3 | (3) |
|
1.4 South Asians and South Asia: definitions and the issue of heterogeneity |
|
|
6 | (2) |
|
1.5 Origins of South Asians and Europeans: implications for genetics |
|
|
8 | (1) |
|
1.6 The immensity of the CVD and DM2 epidemic in South Asia: the case of India |
|
|
9 | (3) |
|
1.7 Inferring high susceptibility and the emergence of epidemics---the role of reference populations for comparison |
|
|
12 | (2) |
|
1.8 A brief introduction to CHD, stroke, and DM2 and especially their known causes |
|
|
14 | (7) |
|
1.9 Explanations for the susceptibility of South Asians to CVD and DM2: outline |
|
|
21 | (1) |
|
1.10 Data artefact: an improbable explanation |
|
|
22 | (2) |
|
1.11 Competing causes: potentially important in examining patterns of death but not usually of morbidity |
|
|
24 | (1) |
|
1.12 Health care access: critically important to progression of CVD and DM2 but not to their occurrence |
|
|
24 | (1) |
|
1.13 The book's approach to the acquisition and synthesis of evidence: literature review and discussions |
|
|
25 | (1) |
|
1.14 The scientific perspective of the book and its author: introducing epidemiology as a clinical, social, environmental, and public health science |
|
|
26 | (4) |
|
1.15 Structure of the book |
|
|
30 | (8) |
|
2 Genetic explanations 1: the thrifty genotype and its variants |
|
|
38 | (20) |
|
|
38 | (1) |
|
|
38 | (1) |
|
2.3 Introduction to genetic hypotheses and to their appeal |
|
|
39 | (3) |
|
2.4 A brief introduction to some elements of genetics relating to evolutionary hypotheses for chronic disease in individuals and populations |
|
|
42 | (2) |
|
2.5 The thrifty genotype hypothesis |
|
|
44 | (4) |
|
2.6 The predation release and drifty genotype hypotheses |
|
|
48 | (1) |
|
2.7 The mitochondrial efficiency hypothesis |
|
|
49 | (2) |
|
|
51 | (7) |
|
3 Genetic explanations 2: adaptations in body size, shape, and composition |
|
|
58 | (17) |
|
|
58 | (1) |
|
|
58 | (1) |
|
|
59 | (1) |
|
3.4 The distribution of body fat and why it matters |
|
|
60 | (3) |
|
3.5 Explaining South Asians' tendency to high levels of adiposity in general and abdominal obesity in particular |
|
|
63 | (2) |
|
3.6 The adipose tissue (compartment) overflow hypothesis |
|
|
65 | (2) |
|
3.7 The variable disease selection hypothesis |
|
|
67 | (1) |
|
3.8 Fat-free mass and the role of muscle |
|
|
68 | (1) |
|
3.9 Other anatomical measures in relation to CVD and DM2 |
|
|
69 | (1) |
|
|
70 | (5) |
|
4 Genetic explanations 3: neurobehavioural explanations |
|
|
75 | (12) |
|
|
75 | (1) |
|
|
75 | (1) |
|
4.3 Introduction to neurobehavioural explanations |
|
|
76 | (2) |
|
4.4 Some reflections on the behavioural switch hypothesis |
|
|
78 | (1) |
|
4.5 Reflections on the aggression control hypothesis |
|
|
79 | (2) |
|
4.6 Further concepts and implications of the neurobehavioural hypotheses of Watve and colleagues |
|
|
81 | (1) |
|
|
81 | (6) |
|
5 The thrifty phenotype and related developmental hypotheses |
|
|
87 | (35) |
|
|
87 | (1) |
|
|
87 | (1) |
|
5.3 The scope and focus of this chapter |
|
|
88 | (1) |
|
5.4 Introduction to the fetal and developmental origins of disease hypotheses |
|
|
88 | (2) |
|
5.5 Birth weight, size, and shape: implications for tile thrifty phenotype hypothesis |
|
|
90 | (3) |
|
5.6 The thrifty phenotype and maternal investment hypotheses |
|
|
93 | (3) |
|
5.7 The DOHAD group of hypotheses specifically in South Asians: an examination of the evidence |
|
|
96 | (19) |
|
5.7.1 The focus of the examination |
|
|
96 | (1) |
|
5.7.2 The association between birth and post-birth measures and the effect of adjustment for `confounders' |
|
|
97 | (9) |
|
5.7.3 Evidence for the DOHAD hypothesis in Indians |
|
|
106 | (7) |
|
5.7.4 Evidence for the DOHAD hypothesis in South Asians in the UK |
|
|
113 | (2) |
|
|
115 | (7) |
|
6 Socio-economic development and the demographic and epidemiological transitions: effects on psychosocial circumstances and lifestyles |
|
|
122 | (17) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
123 | (1) |
|
6.3.1 The demographic and epidemiological transitions |
|
|
123 | (1) |
|
6.4 The spread of the epidemic of CVD and DM2 globally: implications for the epidemic in South Asians |
|
|
124 | (8) |
|
6.4.1 Psychosocial factors: mental health, stresses of migration, and racism |
|
|
128 | (2) |
|
6.4.2 Psychosocial factors in UK South Asians |
|
|
130 | (2) |
|
6.5 Poverty as a cause of CVD and DM2, especially in South Asians |
|
|
132 | (1) |
|
6.6 The influence of wealth: the example of cooking practices |
|
|
133 | (1) |
|
6.7 Conclusions on socio-economic and psychosocial factors |
|
|
134 | (5) |
|
7 Established CVD and DM2 risk factors: reappraisal in relation to South Asians |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
140 | (1) |
|
7.4 High arterial blood pressure |
|
|
141 | (4) |
|
7.5 Lipids including LDL-C and Lp(a) |
|
|
145 | (4) |
|
|
148 | (1) |
|
|
149 | (3) |
|
7.7 Food, diet, and nutrition |
|
|
152 | (5) |
|
7.8 Hyperglycaemia and its consequences |
|
|
157 | (3) |
|
7.9 Obesity, adiposity, and central adiposity |
|
|
160 | (4) |
|
|
164 | (4) |
|
|
168 | (1) |
|
7.12 Explaining the susceptibility of South Asians to CVD and DM, using classical risk factors |
|
|
168 | (2) |
|
|
170 | (3) |
|
8 Other risk factors and explanations |
|
|
173 | (25) |
|
|
173 | (1) |
|
|
173 | (1) |
|
|
174 | (1) |
|
|
174 | (3) |
|
8.5 Vitamin B12, folic acid, and hyperhomocysteinaemia |
|
|
177 | (2) |
|
8.6 The pro-inflammatory state |
|
|
179 | (1) |
|
8.7 Pro-coagulant state: a tendency to blood clotting (thrombosis) |
|
|
180 | (1) |
|
8.8 Infections, microbiota, CVD, and DM2 |
|
|
181 | (3) |
|
|
184 | (1) |
|
8.10 Thyroid dysfunction: an under-investigated postulate |
|
|
185 | (1) |
|
8.11 Milk and lactose intolerance |
|
|
186 | (2) |
|
8.12 Anatomical and physiological explanations |
|
|
188 | (2) |
|
8.13 Miscellaneous risk factors |
|
|
190 | (5) |
|
8.13.1 Other co-morbidities |
|
|
191 | (1) |
|
8.13.2 Other genetic explanations: non-coding DNA and telomeres |
|
|
191 | (1) |
|
8.13.3 Other lifestyles and behaviours |
|
|
191 | (1) |
|
8.13.4 Other biochemical disturbances |
|
|
192 | (1) |
|
8.13.5 Toxins in soil and food |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
194 | (1) |
|
8.13.9 Consanguinity, caste, and other forms of inbreeding |
|
|
194 | (1) |
|
|
195 | (3) |
|
9 A causal synthesis and models |
|
|
198 | (23) |
|
|
198 | (1) |
|
|
198 | (1) |
|
9.3 Introduction: a recapitulation of the main points in Chapters 1-8, and introduction to the nature of this synthesis and the inclusion of international scholars' perspectives |
|
|
199 | (3) |
|
9.4 A simple conceptual causal framework |
|
|
202 | (6) |
|
9.5 CVD: fitting the pieces of the puzzle |
|
|
208 | (4) |
|
9.6 DM2: fitting the pieces of the puzzle |
|
|
212 | (3) |
|
9.7 A summary of causal explanations offered by 22 scholars/researchers |
|
|
215 | (4) |
|
|
219 | (2) |
|
10 Implications for health policy, public health, health care, and research |
|
|
221 | (26) |
|
|
221 | (1) |
|
|
221 | (1) |
|
10.3 Introduction: approaches to intervention, the state of the art, and the need for a new causal synthesis |
|
|
222 | (2) |
|
10.4 Public health policy, public health, health care, and research: principles underlying the current approach |
|
|
224 | (2) |
|
10.5 Current approaches and recommendations on the prevention and control of CVD and DM2 in South Asians |
|
|
226 | (6) |
|
10.6 Impediments to the implementation of recommendations |
|
|
232 | (6) |
|
10.6.1 Lessons from the past for future research on CVD and DM2 in South Asians |
|
|
234 | (4) |
|
10.7 Implications of the research synthesis for the recommendations |
|
|
238 | (5) |
|
10.7.1 Changeability of risk factors and intermediate outcomes |
|
|
238 | (1) |
|
10.7.2 Established risk factors and thresholds |
|
|
239 | (1) |
|
10.7.3 The newer ideas needing further exploration: neo-formed contaminants, arterial stiffness, the vasa vasorum microcirculation, and homeostasis/allostasis |
|
|
240 | (3) |
|
10.8 Effectiveness and sustainability of interventions in practice: the transferability of knowledge to South Asians |
|
|
243 | (1) |
|
|
244 | (3) |
Appendix: Discussions with scholars and researchers |
|
247 | (28) |
References |
|
275 | (60) |
Index |
|
335 | |